Montana Molecular

Montana Molecular

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $11.5M

Overview

Founded in 2009 and based in Bozeman, Montana, Montana Molecular has established itself as a specialized provider of live-cell fluorescent biosensor assays and related viral delivery tools. Its core technology platform utilizes BacMam gene delivery to express genetically encoded biosensors in a wide range of cell types, enabling high-content imaging and functional analysis for academic and industrial drug discovery. The company operates primarily as a tools and services provider, generating revenue through product kits, custom viral vector services, and assay support, positioning it as an enabler for early-stage research and target validation.

NeuroscienceCardiovascular

Technology Platform

Genetically encoded fluorescent biosensors (e.g., for cAMP, DAG, arrestin, cell stress) delivered via BacMam viral vectors for real-time, live-cell imaging and analysis of signaling pathways.

Funding History

3
Total raised:$11.5M
Grant$3M
Series A$6M
Seed$2.5M

Opportunities

Growing demand for physiologically relevant, live-cell assays in drug discovery, particularly for GPCR targets and complex diseases like neurodegeneration and diabetes.
Expansion of custom viral vector and data analysis services offers higher-margin revenue streams and deeper client engagement.

Risk Factors

Faces competition from larger life science reagent companies and academic labs.
Reliance on the adoption of BacMam technology and live-cell imaging trends.
As a small, private company, scaling operations and managing intellectual property in a crowded field are ongoing challenges.

Competitive Landscape

Competes with large reagent suppliers (e.g., Thermo Fisher, Revvity) offering broad assay portfolios and with academic labs that publish novel biosensors. Differentiates through specialized expertise in BacMam delivery, a focused product line for signaling pathways, and strong technical support and custom service capabilities.